Allergy Diagnostics Market to Reach US$ 11.63 Bn by 2030 at 10.4% CAGR | Key Players: Danaher, BioMérieux, Thermo Fisher, Siemens, HOB Biotech

The Global Allergy Diagnostics Market was valued at US$ 6.54 billion in 2024 and is expected to reach US$ 11.63 billion by 2030, growing at a CAGR of 10.4% during the forecast period 2025-2030. Market expansion is driven by the rising prevalence of allergic diseases, such as respiratory allergies, food allergies and drug hypersensitivities, along with increasing pollution levels, lifestyle changes and heightened patient awareness. Allergy diagnostics, including test kits, analyzers and in-vitro diagnostic solutions, continue to gain importance as healthcare systems emphasize early detection and personalized treatment approaches.

Demand is also rising due to the growing adoption of advanced diagnostic technologies such as immunoassays, molecular allergy testing and multiplex screening systems, which offer higher accuracy and faster results. North America remains the largest market due to strong healthcare infrastructure and high testing volumes, while Asia-Pacific is emerging as the fastest-growing region driven by rapid urbanization, improved healthcare access and increasing awareness of allergy management. As allergy cases continue to rise globally, the need for reliable, precise and non-invasive diagnostic tools will further accelerate market growth.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/allergy-diagnostics-market?sai-v

The Allergy Diagnostics Market improves patient outcomes with fast, accurate testing technologies that identify allergens and support targeted treatment.

Key Developments
✅ May 2025: Hospitals across the United States adopted AI-enabled in vitro allergy testing platforms to improve accuracy in detecting environmental and food allergens, reducing false-positive rates.

✅ June 2025: Clinics in Germany implemented next-generation multiplex immunoassay systems capable of identifying over 150 allergen components in a single test, supporting faster diagnosis.

✅ July 2025: Allergy centers in Japan introduced rapid point-of-care IgE testing devices to expand early detection of pediatric food allergies and streamline outpatient workflows.

✅ August 2025: Healthcare providers in Australia integrated smartphone-connected skin prick testing devices to digitally record results and enhance patient allergy monitoring.

✅ September 2025: Medical laboratories in Canada deployed cloud-enabled laboratory information systems to better manage high-volume allergy testing data and ensure real-time results for physicians.

✅ October 2025: Hospitals in India adopted advanced molecular allergy diagnostics with recombinant allergens to provide more precise treatment pathways for asthma, rhinitis, and atopic dermatitis.

Mergers & Acquisitions
✅ June 2025: A major U.S. diagnostics company acquired a domestic allergy test reagent manufacturer to strengthen its portfolio in in vitro allergy and immunology testing.

✅ August 2025: A leading European diagnostic solutions provider partnered with a Japanese medical device company to co-develop high-sensitivity allergy testing analyzers.

✅ October 2025: An Asia-based biotechnology firm completed the acquisition of a European allergy diagnostics startup specializing in molecular allergen panels to expand its global footprint.

Key Players
BioMérieux SA | Danaher Corporation | Showa Denko Materials Co., Ltd. (Hitachi Chemical Diagnostics) | HOB Biotech Group Corp. Ltd. | HYCOR Biomedical | Lincoln Diagnostics Inc. | Omega Diagnostics Group Plc | Siemens Healthineers AG | Stallergenes Greer Ltd. | Thermo Fisher Scientific Inc.

Key Highlights
• BioMérieux SA - Holds an estimated 16.8% share, driven by its strong global footprint, advanced diagnostic platforms, and leadership in immunoassay-based allergy testing.

• Danaher Corporation - Accounts for around 18.3% share, supported by its powerful diagnostics portfolio, integrated laboratory automation solutions, and robust R&D strength across clinical testing technologies.

• Showa Denko Materials Co., Ltd. (Hitachi Chemical Diagnostics) - Maintains approximately 9.7% share, fueled by its high-quality in-vitro allergy testing kits and growing demand for precise allergen-specific diagnostics.

• HOB Biotech Group Corp. Ltd. - Represents nearly 6.2% share, recognized for its cost-effective in-vitro allergy detection systems and strong penetration in Asian markets.

• HYCOR Biomedical - Holds about 7.4% share, driven by its innovative automated allergy testing instruments and strong customer base in clinical laboratories.

• Lincoln Diagnostics Inc. - Accounts for around 4.3% share, supported by its leadership in skin testing diagnostic kits and widespread use among allergists globally.

• Omega Diagnostics Group Plc - Maintains roughly 5.1% share, backed by its growing allergy and immunology testing segment and expanding presence in emerging markets.

• Siemens Healthineers AG - Represents approximately 14.2% share, recognized for its high-throughput immunodiagnostic systems and expanding portfolio of allergy-specific assays.

• Stallergenes Greer Ltd. - Holds an estimated 6.9% share, driven by its strong specialization in allergen extracts, immunotherapy solutions, and diagnostic services.

• Thermo Fisher Scientific Inc. - Accounts for around 11.1% share, supported by its world-leading ImmunoCAP allergy testing technology and strong global distribution network.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=allergy-diagnostics-market?sai-v

Market Drivers

- Growing global prevalence of allergic disorders, including asthma, rhinitis, food allergies, and dermatitis, is driving demand for early and accurate diagnosis.

- Increasing awareness among healthcare providers and patients, along with public health initiatives, is promoting routine allergy testing.

- Rising adoption of in vitro diagnostic (IVD) tests, such as immunoassays and molecular allergology, enables fast and precise identification of allergens.

- Advancements in automated analyzers, multiplex assays, and point-of-care testing devices are enhancing efficiency and diagnostic accuracy.

- Expansion of personalized medicine approaches is fueling demand for component-resolved diagnostics (CRD) and detailed allergen profiling.

- Growing exposure to environmental allergens, pollution, and lifestyle-related triggers is increasing the need for diagnostic solutions.

- Investments in healthcare infrastructure and specialized diagnostic laboratories are supporting the market's growth.

Industry Developments

- Introduction of next-generation multiplex allergen panels enabling simultaneous detection of multiple allergens.

- Strategic partnerships between diagnostic companies and clinical laboratories to expand testing capabilities and geographic reach.

- Development of highly sensitive molecular allergen components improving diagnostic precision and personalized treatment.

- Rising investment in AI-driven allergy interpretation tools for accurate, data-supported treatment planning.

- Increased availability of rapid point-of-care allergy testing kits for primary care settings.

- Expansion of home-based sample collection services supporting laboratory-based allergy testing and patient convenience.

Regional Insights

North America, accounting for 40% of the market, is driven by high allergy prevalence, strong diagnostic infrastructure, and early adoption of molecular testing technologies.

Europe, representing 30% of the market, is supported by advanced healthcare systems, increasing demand for component-resolved diagnostics, and rising focus on environmental allergies.

Asia Pacific, capturing 20% of the market, is fueled by growing patient awareness, increasing pollution levels, and the expansion of diagnostic laboratories.

Latin America, holding 6% of the market, is driven by expanding healthcare access and rising adoption of immunoassay-based diagnostic methods.

Middle East & Africa, accounting for 4% of the market, is supported by increasing cases of asthma and allergic rhinitis and gradual improvement in diagnostic resources.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/allergy-diagnostics-market?sai-v

Key Segments

➥ By Product Type
Assay kits are widely used for detecting and quantifying allergens in clinical and research settings. They offer standardized protocols, high accuracy, and reproducibility, making them essential for diagnostic, monitoring, and research purposes. Consumables include reagents, buffers, plates, and other laboratory supplies that support assay performance, sample processing, and overall laboratory efficiency.

➥ By Allergen Type
Inhaled allergens cover pollen, dust mites, mold, and pet dander, commonly tested to diagnose respiratory allergies and asthma. Food allergens include milk, nuts, shellfish, eggs, and other dietary triggers, critical for identifying food sensitivities and guiding dietary management. Drug allergens involve antibiotics, vaccines, and other medications, supporting safe prescription practices and preventing adverse immune responses.

➥ By End User
Hospital-based laboratories utilize allergen testing for patient diagnosis, monitoring, and treatment planning within clinical workflows. Diagnostic laboratories provide specialized services for allergy testing, personalized care, and high-throughput sample analysis. Academic research laboratories employ allergen assay kits and consumables for immunology studies, epidemiology research, and the development of novel diagnostic tools.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.